Advertising
Showing 1 to 15 of 30 entries
BUY
Real-time, remote medical reporting from patient to care providers. Fits and starts over the years. Should be rolling up to cashflow positive. Nice runway with great growth rate. Adding new partners. Monthly subscription. Could have a bright future in next couple of years.
computer parts mnfctr
TOP PICK
Remote monitoring business. When people leave the hospital, they have the technology to help monitor them. Gives the ability to track and keep healthcare costs down. Continues to add more doctor groups and healthcare regions that are recurring revenue streams. $24M run rate for this year. Margin is 45%. Valuation is attractive.
computer parts mnfctr
TOP PICK
Remote monitoring of chronic disease. Real-time reporting to doctors. Slowed by Covid. Cashflow positive this quarter. Subscription model. Solid growth trajectory. CEO has a lot of skin in the game. No dividend.
computer parts mnfctr
BUY
It has a great product and is coming back after stubbing its toe three years ago. The market now likes it. Good opportunity for the company going forward, because telemedicine is in vogue and the US government will pay for results-based compensation.
computer parts mnfctr
WATCH
They said they will be cash flow positive moving into 2020. If they have the growth rate they are projecting, then you will see the stock start to move again. Right now it is in the penalty box.
computer parts mnfctr
DON'T BUY
It hasn't done well due to accounting issues. He recommnded it before, but hasn't gone back to this. Too many compliance issues here. He's heard that revenues and contracts look positive. No, he's been burned and avoids this.
computer parts mnfctr
DON'T BUY
A former top pick. They have long-term potential, but need to show they can add clients and be cash-flow positive. The stock is starting to recover.
computer parts mnfctr
DON'T BUY
He exited this story and is not going back to it because of structural problems. But it has gone up since then.
computer parts mnfctr
WATCH
It was a past Top Pick, but he is not in it today. back in 2018 they were adding patients and there were high expectations on growing cash flow. Then they had cash flow recognition issue on the accounting side as patients were slower to sign on than expected. If they can deal with those issues it will become a cash flow machine. They have cash on hand to help grow the company.
computer parts mnfctr
PAST TOP PICK
(A Top Pick Dec 21/17, Down 76%) They exited this position. He entered around $0.80 and exited a large position around $1.80. The company faced a down turn in October after they had revenue recognition issues and contracts that had been signed and that is when they exited. He needs to see management prove up revenues before re-entering.
computer parts mnfctr
PAST TOP PICK
(A Top Pick Nov 08/17, Down 54%) He sold out as high as $2.35 and then again at $0.85. Having stops with these small companies is important. They simply have not been able to execute as they promised. Now they have revenue recognition issues with their reporting.
computer parts mnfctr
SELL

He recommended it two years ago. Recently they warned that revenues would be delayed. They have governance issues too. He sold his shares. He saw too many red flags and expects lawsuits against them. He feels bad, because he recommended this stock. He has no confidence in management. Sometimes you have to take your lumps.

computer parts mnfctr
DON'T BUY

Unfortunately their technology has been slowing getting out into the market and now they have a receivables collection financial issue. It does not look good, he says.

computer parts mnfctr
PAST TOP PICK

(A Top Pick Oct 12/17, Up 175%) It is advanced monitoring in the home. There are delays in their hardware. The market is starting to question if they will miss their guidance for the end of the year.

computer parts mnfctr
COMMENT

A high-risk company in an interesting space. Healthcare providers and governments want to keep people out of hospitals, so Reliq benefits. Reliq's technology can monitor people recovering from home. They're signing contracts in Texas. They target $26 million annual recurring revenue. They've had a few product missteps, so they need to deliver that $26 million target. They're also in the process of signing contracts in Canada and Australia. This could be a big business one day, but there's a lot of risk here.

computer parts mnfctr
Showing 1 to 15 of 30 entries

Reliq Health Techniques(RHT-X) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 2

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 2

Stockchase rating for Reliq Health Techniques is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Reliq Health Techniques(RHT-X) Frequently Asked Questions

What is Reliq Health Techniques stock symbol?

Reliq Health Techniques is a Canadian stock, trading under the symbol RHT-X on the TSX Venture Exchange (RHT-CV). It is usually referred to as TSXV:RHT or RHT-X

Is Reliq Health Techniques a buy or a sell?

In the last year, 2 stock analysts published opinions about RHT-X. 2 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Reliq Health Techniques.

Is Reliq Health Techniques a good investment or a top pick?

Reliq Health Techniques was recommended as a Top Pick by on . Read the latest stock experts ratings for Reliq Health Techniques.

Why is Reliq Health Techniques stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Reliq Health Techniques worth watching?

2 stock analysts on Stockchase covered Reliq Health Techniques In the last year. It is a trending stock that is worth watching.

What is Reliq Health Techniques stock price?

On 2022-01-26, Reliq Health Techniques (RHT-X) stock closed at a price of $1.